RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vakaramoko Diaby to Male

This is a "connection" page, showing publications Vakaramoko Diaby has written about Male.
Connection Strength

0.475
  1. Sanogo V, Saud Almutairi RD, Diaby V. Budget impact of lecanemab for medicare beneficiaries with early Alzheimer's disease in the United States: a subgroup analysis. Expert Rev Pharmacoecon Outcomes Res. 2025 Dec; 25(10):1421-1426.
    View in: PubMed
    Score: 0.059
  2. Diaby V, Pandey S, Sanogo V, Dhayan Almutairi R, Kanoria Y, Nag SS. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with schizophrenia in the United States. J Manag Care Spec Pharm. 2025 Jan; 31(1):53-59.
    View in: PubMed
    Score: 0.057
  3. Diaby V, Pandey S, Sanogo V, Almutairi RD, Kanoria Y, Nag SS. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with bipolar I disorder in the United States. J Manag Care Spec Pharm. 2025 Jan; 31(1):60-67.
    View in: PubMed
    Score: 0.057
  4. Tran PT, Riaz M, Chen Z, Truong CB, Diaby V. An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines. Clin Drug Investig. 2022 May; 42(5):377-390.
    View in: PubMed
    Score: 0.048
  5. Okere AN, Sanogo V, Alqhtani H, Diaby V. Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach. Expert Rev Pharmacoecon Outcomes Res. 2021 Oct; 21(5):1043-1048.
    View in: PubMed
    Score: 0.043
  6. Nkemdirim Okere A, Sanogo V, Balkrishnan R, Diaby V. A quantitative analysis of the effect of continuity of care on 30-day readmission and in-hospital mortality among patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):105053.
    View in: PubMed
    Score: 0.042
  7. Moussa RK, Diaby V. Self-assessed life expectancy among older adults in C?te d'Ivoire. BMC Public Health. 2020 Jun 15; 20(1):932.
    View in: PubMed
    Score: 0.042
  8. Okere AN, Ezendu K, Berthe A, Diaby V. An Evaluation of the Cost-effectiveness of Comprehensive MTM Integrated with Point-of-Care Phenotypic and Genetic Testing for U.S. Elderly Patients After Percutaneous Coronary Intervention. J Manag Care Spec Pharm. 2018 Feb; 24(2):142-152.
    View in: PubMed
    Score: 0.035
  9. Diaby V, Di? Kakou H, Lachaine J. Eliciting preferences for reimbursed drugs selection criteria in C?te d'Ivoire. Patient. 2011; 4(2):125-31.
    View in: PubMed
    Score: 0.022
  10. Garg M, Venugopalan V, Vouri SM, Diaby V, Iovine NM, Wilson DL, Park H. Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018. Pharmacotherapy. 2024 Sep; 44(9):701-710.
    View in: PubMed
    Score: 0.014
  11. Tran PT, Nduaguba SO, Wang Y, Diaby V, Finelli L, Choi Y, Winterstein AG. Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5?Years of Age in the USA. Influenza Other Respir Viruses. 2024 07; 18(7):e13347.
    View in: PubMed
    Score: 0.014
  12. Jiang X, Vouri SM, Diaby V, Lo-Ciganic W, Parker R, Park H. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C. J Manag Care Spec Pharm. 2021 Oct; 27(10):1388-1402.
    View in: PubMed
    Score: 0.011
  13. Jiang X, Parker RL, Vouri SM, Lo-Ciganic W, Diaby V, Henry L, Park H. Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders. Am J Prev Med. 2021 10; 61(4):576-584.
    View in: PubMed
    Score: 0.011
  14. Tran AD, Fogarty G, Nowak AK, Diaby V, Hong A, Watts C, Morton RL. Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases. Appl Health Econ Health Policy. 2020 10; 18(5):679-687.
    View in: PubMed
    Score: 0.011
  15. Wang CY, Pham PN, Kim S, Lingineni K, Schmidt S, Diaby V, Brown J. Predicting Cost-Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States. Clin Transl Sci. 2020 03; 13(2):352-361.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support